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On page 1667 of this issue, Stuart Smith and col-
leagues [1] demonstrate that the animal fatty acid syn-
thase is a head-to-head dimer rather than the head-to-
tail dimer depicted in textbooks. This has important
ramifications for the mechanisms of other multifunc-
tional enzymes such as polyketide synthases [2].
Fatty acid synthesis in vertebrates is catalyzed by three
distinct enzyme systems. Two organellar systems exist,
one for the synthesis of lipoic acid and one for synthe-
sis of very long chain sphingolipid fatty acids from
shorter acids made in the cytosol. The third system,
that responsible for synthesis of the great bulk of the
fatty acid moieties of the membrane lipids, is the cyto-
solic fatty acid synthase (FAS). The animal FAS is a very
large protein composed of two identical multifunctional
polypeptides of 272 kDa each structured into discrete
domains that together possess all seven of the active
sites required to synthesize fatty acids from malonyl-
CoA [3]. Despite the fact that each subunit contains all
the required catalytic sites, the monomeric protein is
not proficient in fatty acid synthesis—only the dimeric
protein is active. Early biochemical work suggested
that the two subunits lay side-by-side in a fully ex-
tended antiparallel orientation [4–6]. However, later
studies with wild-type and mutant proteins began to
erode confidence in the head-to-tail model. Now, Smith
and coworkers use molecular modeling, crosslinking,
and mass spectrometry to provide compelling evidence
that the monomers actually lie in a head-to-head con-
figuration [1].
In the early 1980s, Salih Wakil and his coworkers set
out to understand why activity resided solely in the di-
meric protein [7, 8]. By that time, model substrate en-
zymatic assays of proteolytic fragments and covalent
labeling of the fragments with intermediates and inhibi-
tors led the idea of the sites being arrayed as beads on
a string. The first bead is the 3-ketoacyl synthase (KS)
domain and the next to last is the acyl carrier protein
(ACP) domain, which carries a 4#-phosphopanthetheine
(4#-PP) prosthetic group [3, 4]. In the course of fatty
acid synthesis, the ACP domain must interact with each
of the active sites since the growing acyl chain is at-
tached to the thiol of the 4#-PP moiety [3, 4]. In most
of the active sites the ACP domain acts only to position
the substrate and to facilitate chemistry. However, the
interaction between the KS and ACP domains is more
intimate. The first step in the elongation cycle is
transfer of the acyl chain from the 4#-PP thiol to that of
an unusually reactive cysteine residue (pKa 6.5) in the
KS active site to form an acyl-enzyme intermediate [3,
4]. Early studies revealed crosslinks formed between
the reactive KS cysteine and cystamine formed from
the thiol end of 4#-PP at a ratio that was consistent with
a dimer composed from two different monomers [5, 7,
8]. In this head-to-tail configuration, the dimeric en-
zyme, although organized horizontally, was verticallybisected in function. The left half of the dimer would
comprise one functional fatty acid synthesis catalytic
center whereas the right half would comprise the se-
cond catalytic center. This picture provided a tidy ex-
planation for the dependence of activity on dimeriza-
tion and the head-to-tail model therefore became
generally accepted [4–6].
In the mid 1990s, however, in vitro mutagenesis tech-
niques coupled with improved methods of protein ex-
pression and manipulation were brought to bear on FAS
structure and mechanism by Smith and coworkers [9,
10]. The early experiments were not targeted at testing
the model. Indeed, the Smith group had interpreted
their prior data in terms of the head-to-tail dimer model
[5]. The first technical advance was high-level expres-
sion of the human FAS in the baculovirus system, which
gave a source of high-quality protein [10]. The baculovi-
rus system also allowed the use of multiple N-terminal
affinity tags in purification. By using two different tags,
heterodimers composed of two monomers that differed
in the activities of their catalytic centers could be as-
sembled and isolated [9]. Because only the heterodi-
mers bound to both affinity columns, homodimers of
one or the other monomer could be readily removed by
successive affinity chromatography steps [9]. This ap-
proach allowed complementation analyses [11, 12].
Complementation was observed between monomers
that were mutant in what were different fatty acid syn-
thetic centers according to the head-to-tail model [11,
12]. In the extreme case, a dimer composed of a mono-
mer lacking the nucleophilic thiol of the KS domain
paired with a monomer lacking the essential 4#-PP
prosthetic group had significant activity [12]. The head-
to-tail model could clearly not accommodate these re-
sults.
Last year in pounding a penultimate nail into the cof-
fin of the 1980s model, the Smith laboratory reported
construction of a dimeric FAS composed of a wild-type
monomer and a seven-knock-out mutant monomer in
which function of each of the active sites had been de-
stroyed by mutation [13]. This dimer had a very respect-
able FAS activity. The possibility that the activity was
due to reassortment of the monomers to form an active
enzyme was meticulously ruled out. Although the het-
erodimer results were incompatible with the head-to-
tail model, they failed to provide positive evidence for
the arrangement of the monomers in the active dimeric
FAS. The Smith group has done that now by focusing
on the N-terminal KS domain [1]. It was first found that
the N-terminal 40% of the protein had association-
dissociation properties identical to those of the intact
FAS. Smith and coworkers then took advantage of the
fact that the active site of the KS domain could be read-
ily modeled on the crystal structures of FabF, a dimeric
protein that is the generic KS of bacterial fatty acid syn-
thesis [2]. Using this model, they introduced specific
cysteine residues within the N-terminal region of the
full-length protein and found rapid and efficient cross-
linking with bifunctional reagents. Construction of het-
erodimers in which only one of the two subunits carried
an introduced cysteine showed that both introduced
cysteine residues were required for crosslinking. The
standard of proof was moved beyond convincing to
compelling by mass spectroscopic documentation of
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Dduction of a cleavage site for TEV protease down-
stream of the introduced cysteine residues. The cross- D
Ulinked proteins were then digested with TEV to liberate
Uthe crosslinked peptides for purification followed by
characterization by mass spectroscopy. The mass
Sspectral analyses demonstrated that indeed the de-
signed crosslinks between the KS domains had been
formed, and thus the dimer must be composed of
monomers in a head-to-head configuration. These ex-
periments provide a platinum standard of crosslinking
analysis.
The detailed FAS structure remains to be established,
but the complementation data argue that the regions
of the two subunits downstream of the KS domain are
somehow coiled together and this coiling is required
to hold each monomer in the proper conformation for
catalysis. Recent cryo-electron microscopy data suggest
that the FAS dimer has an extremely flexible H-shaped
structure [14–16]. The present data argue that the KS
domain makes up the cross-stroke of the H. Why did
the head-to-tail model seem so reasonable (and why
1was head-to-head evidence missed) in the 1980s? I be-
1lieve this was largely due to the weakness of the tools
then available compared to the size and complexity of 1
FAS. SDS gel resolution of large proteins was poor and
mass spectroscopy of large molecules would have 1
been only a dream. Despite this wrong turn, it seems
1unlikely to me that the incorrect head-to-tail model seri-
ously impeded progress with FAS. The difficulties have
1
been technical, rather than conceptual, and working
with such large enzymes remains a formidable chal- 1
lenge.ohn E. Cronan, Jr.
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